tirzepatide pregnancy risks (Zepbound) for weight loss Tirzepatide and Pregnancy: Safety Facts

Semaglutide reduced heart attacks, strokes and cardiovascular death by 20% in the SELECT trial

This is likely secondary to decrease water intake due to nausea

Patients taking SGLT2 inhibitors should not participate in nutritional ketosis due to the increased risk of diabetic ketoacidosis

Depuis le 23 juin 2025, tout mdecin peut prescrire le Mounjaro gnraliste compris aussi bien pour initier que pour renouveler le traitement

In clinical trials, people using semaglutide lost a significant amount of weight compared to those who did not take the drug

Microdosing can be used to gradually taper a dosage down to zero, stretching out your supply rather than ending your usage abruptly